Evidence map›Paper›PMID 38935737›Full record

ArticleScience (New York, N.Y.)2024

Antibody inhibition of measles virus entry.

Hector C Aguilar

Abstract readComment
PubMed Publisher
In one paragraph

Article in Science (New York, N.Y.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Hector C AguilarDepartment of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA.

Funding

Mechanisms of Nipah virus fusion and entryR01AI109022 · NIAID · WASHINGTON STATE UNIVERSITY · PI AGUILAR-CARRENO, HECTOR · 2014 to 2024
$4.3M
Crossing scales to predict and prevent bat virus zoonoses in a Madagascar ecosystemDP2AI171120 · NIAID · UNIVERSITY OF CHICAGO · PI Cara Brook · 2022 to 2026
$2.5M
Mechanism of membrane inactivation method to prepare enveloped virus vaccinesR21AI156731 · NIAID · CORNELL UNIVERSITY · PI AGUILAR-CARRENO, HECTOR · 2021 to 2022
$444k
NIAID NIH HHS DP2 AI171120NIAID NIH HHS R01 AI109022NIAID NIH HHS R21 AI156731
6 · The paper itself

Abstract

An intermediate virus-cell fusion step is revealed by an antibody with therapeutic potential.

Indexed as

Antibodies, MonoclonalAntibodies, NeutralizingAntibodies, ViralMeaslesMeasles virusVirus InternalizationAnimalsHumansAntibodies, MonoclonalAntibodies, NeutralizingAntibodies, Viral

Identifiers

PMID38935737

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.